MSB 3.21% $1.13 mesoblast limited

Cell Therapy News/Articles, page-12381

  1. 4,959 Posts.
    lightbulb Created with Sketch. 782
    They don’t work old sport. That’s the fundamental problem with this company. It just doesn’t work.

    That’s why:
    • the trials fail.
    • they have to cut and dice and dissect the trial data
    • there have been no partnership
    • there has been no buy out
    • there is no EUA in a global pandemic
    • there is always something just around the corner, but always remains just out of reach
    • no one, but no one who really knows what they are looking at has touched this product


    For 18 years.

    Really, you should look beyond what you want to believe to be the case. Because you believe very strongly won’t make it happen the way you want. That’s not how it works.

    I think there’s plenty of evidence to show stems just don’t work.

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.